1. Home
  2. EVO vs EH Comparison

EVO vs EH Comparison

Compare EVO & EH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • EH
  • Stock Information
  • Founded
  • EVO 1993
  • EH 2014
  • Country
  • EVO Germany
  • EH China
  • Employees
  • EVO N/A
  • EH N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • EH Military/Government/Technical
  • Sector
  • EVO Health Care
  • EH Industrials
  • Exchange
  • EVO Nasdaq
  • EH Nasdaq
  • Market Cap
  • EVO 1.2B
  • EH 1.4B
  • IPO Year
  • EVO 2021
  • EH 2019
  • Fundamental
  • Price
  • EVO $3.93
  • EH $18.72
  • Analyst Decision
  • EVO Strong Buy
  • EH Strong Buy
  • Analyst Count
  • EVO 1
  • EH 3
  • Target Price
  • EVO $7.00
  • EH $24.80
  • AVG Volume (30 Days)
  • EVO 44.7K
  • EH 1.4M
  • Earning Date
  • EVO 11-05-2025
  • EH 11-17-2025
  • Dividend Yield
  • EVO N/A
  • EH N/A
  • EPS Growth
  • EVO N/A
  • EH N/A
  • EPS
  • EVO N/A
  • EH N/A
  • Revenue
  • EVO $912,894,891.00
  • EH $65,001,814.00
  • Revenue This Year
  • EVO N/A
  • EH $16.86
  • Revenue Next Year
  • EVO $10.78
  • EH $87.98
  • P/E Ratio
  • EVO N/A
  • EH N/A
  • Revenue Growth
  • EVO N/A
  • EH 87.04
  • 52 Week Low
  • EVO $2.84
  • EH $12.02
  • 52 Week High
  • EVO $5.64
  • EH $29.76
  • Technical
  • Relative Strength Index (RSI)
  • EVO 59.84
  • EH 56.73
  • Support Level
  • EVO $3.93
  • EH $18.76
  • Resistance Level
  • EVO $4.02
  • EH $20.20
  • Average True Range (ATR)
  • EVO 0.08
  • EH 0.83
  • MACD
  • EVO 0.04
  • EH 0.06
  • Stochastic Oscillator
  • EVO 78.26
  • EH 53.39

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About EH EHang Holdings Limited ADS

EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.

Share on Social Networks: